Literature DB >> 23036155

Impact of age on epidermal growth factor receptor mutation in lung cancer.

Tsuyoshi Ueno1, Shinichi Toyooka, Kenichi Suda, Junichi Soh, Yasushi Yatabe, Shinichiro Miyoshi, Keitaro Matsuo, Tetsuya Mitsudomi.   

Abstract

Aging is one of the best, but rarely referred, risk factors for various types of cancer including lung cancer, because age could be a surrogate for accumulation of genetic events in cancers. Smoking inversely associates with the presence of epidermal growth factor receptor (EGFR) mutation in lung cancer, but its strong confounding with age and sex makes it difficult to evaluate sole impact of age. To clarify an impact of age on EGFR mutation, we conducted a cross-sectional study based on data of 1262 lung cancer patients. The associations between EGFR mutation and age, considering sex, smoking and histology, were evaluated using logistic regression models. In multivariate analysis, we found a significant increase of EGFR mutation prevalence by increase of age (p-trend=0.0004). Consistent trend was observed among never-smoking females (p-trend=0.011) and never-smoking males also showed similar trend although not significant. These were consistently observed when we limit the subject to those with adenocarcinoma. In conclusion, age independently associates with EGFR mutation among lung cancer. Positive association between EGFR mutation and age among never-smokers regardless of sex might indicate that EGFR mutation occurs cumulatively by unidentified internal/external factors other than smoking.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036155     DOI: 10.1016/j.lungcan.2012.09.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  20 in total

1.  Methodological comparison of the allele refractory mutation system and direct sequencing for detecting EGFR mutations in NSCLC, and the association of EGFR mutations with patient characteristics.

Authors:  Minmin Wu; Xiaodong Pan; Yaya Xu; Siying Wu; Xiuling Wu; Bicheng Chen
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

2.  Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis.

Authors:  Hye-Ryoun Kim; Seo Yun Kim; Cheol Hyeon Kim; Sung Hyun Yang; Jae Cheol Lee; Chang-Min Choi; Im Il Na
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-08       Impact factor: 4.553

3.  Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy.

Authors:  Qiaoyou Weng; Junguo Hui; Hailin Wang; Chuanqiang Lan; Jiansheng Huang; Chun Zhao; Liyun Zheng; Shiji Fang; Minjiang Chen; Chenying Lu; Yuyan Bao; Peipei Pang; Min Xu; Weibo Mao; Zufei Wang; Jianfei Tu; Yuan Huang; Jiansong Ji
Journal:  Front Oncol       Date:  2021-08-06       Impact factor: 6.244

4.  Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer.

Authors:  Evgeny N Imyanitov; Irina A Demidova; Marat G Gordiev; Maxim L Filipenko; Tatyana V Kekeyeva; Yuri K Moliaka; Polina A Gervas; Valeriy B Kozhemyako; Dmitriy I Vodolazhskiy; Liubov A Sergeyeva; Dinara U Fattakhova; Aglaya G Iyevleva; Natalia V Mitiushkina; Ekatherina Sh Kuligina; Alexey A Barinov; Meriiam S Mommaeva; Svetlana N Aleksakhina; Ilya V Tsimafeyeu; Sergey A Tjulandin
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

5.  Genomic alterations and survival in young patients aged under 40 years with completely resected non-small cell lung cancer.

Authors:  Shifeng Yang; Zhengbo Song; Guoping Cheng
Journal:  Ann Transl Med       Date:  2019-04

6.  A large-scale cross-sectional study of ALK rearrangements and EGFR mutations in non-small-cell lung cancer in Chinese Han population.

Authors:  Shaodong Hong; Wenfeng Fang; Zhihuang Hu; Ting Zhou; Yue Yan; Tao Qin; Yanna Tang; Yuxiang Ma; Yuanyuan Zhao; Cong Xue; Yan Huang; Hongyun Zhao; Li Zhang
Journal:  Sci Rep       Date:  2014-12-01       Impact factor: 4.379

7.  Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer.

Authors:  Teppei Nishii; Tomoyuki Yokose; Yohei Miyagi; Yataro Daigo; Hiroyuki Ito; Tetsuya Isaka; Kentaro Imai; Shuji Murakami; Tetsuro Kondo; Haruhiro Saito; Fumihiro Oshita; Kouzo Yamada; Shoichi Matsukuma; Masahiro Tsuboi; Haruhiko Nakayama; Munetaka Masuda
Journal:  BMC Cancer       Date:  2014-08-25       Impact factor: 4.430

8.  Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays.

Authors:  Hirotsugu Kenmotsu; Masakuni Serizawa; Yasuhiro Koh; Mitsuhiro Isaka; Toshiaki Takahashi; Tetsuhiko Taira; Akira Ono; Tomohiro Maniwa; Shoji Takahashi; Keita Mori; Masahiro Endo; Masato Abe; Isamu Hayashi; Takashi Nakajima; Yasuhisa Ohde; Nobuyuki Yamamoto
Journal:  BMC Cancer       Date:  2014-10-28       Impact factor: 4.430

9.  Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers.

Authors:  Boram Lee; Taebum Lee; Se-Hoon Lee; Yoon La Choi; Joungho Han
Journal:  Oncotarget       Date:  2016-04-26

10.  Detection of EGFR gene mutations in non-small cell lung cancer: lessons from a single-institution routine analysis of 1,403 tumor samples.

Authors:  Audrey Vallee; Christine Sagan; Anne-Gaelle Le Loupp; Kalyane Bach; Thomas Dejoie; Marc G Denis
Journal:  Int J Oncol       Date:  2013-08-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.